
Treatment for Asherman’s syndrome
There are two approaches to treating Asherman’s Syndrome: surgical and non-surgical. Surgical treatment involves surgically removing uterine scar tissue (adhesions) using hysteroscopy (cutting with micro-scissors or lasers) to restore the normal uterine cavity, followed by hormonal therapy (estrogen) and sometimes placement of devices or repeated procedures to prevent scar tissue from reforming, aiming to restore menstruation and fertility. While often successful, patients run the risks of repeat adhesions and the risk of general anesthesia.
Repeat adhesions can form in the uterus as the body forms post-surgical adhesions. A five-decade study in Digestive Surgery showed that 55% to 100% of women develop adhesions following pelvic surgery. (Liakakos et al, 2001) Even laparoscopy, one of the least invasive surgical procedures, was shown to cause new adhesions in 97% of cases at the exact site surgery was performed (Journal of Laparoscopy, 2020).
Non-surgical treatment: Clear Passage® Therapy is a non-surgical, manual physical therapy approach specifically designed to decrease adhesions such as those associated with Asherman’s Syndrome. It has the distinct advantage of being non-surgical. As such, it avoids subjecting the patient to surgery, a primary cause of Asherman’s Syndrome.
Clear Passage® uses hands-on techniques developed over several decades of research to gently mobilize and soften scar tissue in and around the pelvic region. Besides decreasing adhesions, its primary goals include improving uterine and pelvic organ mobility, circulation, and function. Treatment programs are individualized and typically provided over an intensive period of consecutive days by trained therapists.
